Quelles complications peuvent survenir avec le lymphome intraoculaire ?
Les complications incluent la perte de vision, le glaucome et des infections secondaires.
ComplicationsPerte de visionGlaucome
#2
Le lymphome intraoculaire peut-il entraîner des métastases ?
Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare.
MétastasesPropagationRare
#3
Comment le traitement peut-il causer des complications ?
Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections.
ChimiothérapieSystème immunitaireInfections
#4
Le suivi régulier peut-il prévenir les complications ?
Oui, un suivi régulier permet de détecter et de traiter rapidement les complications.
Suivi régulierPréventionComplications
#5
Quelles sont les complications à long terme possibles ?
Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements.
Complications à long termeProblèmes de visionEffets secondaires
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque du lymphome intraoculaire ?
Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections.
Facteurs de risqueImmunodépressionInfections
#2
Les antécédents familiaux augmentent-ils le risque ?
Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie.
Antécédents familiauxRisqueLymphome
#3
Les personnes immunodéprimées sont-elles plus à risque ?
Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru.
ImmunodépressionVIHRisque accru
#4
Certaines infections virales sont-elles des facteurs de risque ?
Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome.
Infections viralesVirus Epstein-BarrRisque accru
#5
L'exposition à des produits chimiques augmente-t-elle le risque ?
Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome.
Produits chimiquesExpositionRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphome intraoculaire : Questions médicales les plus fréquentes",
"headline": "Lymphome intraoculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphome intraoculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lymphomes",
"url": "https://questionsmedicales.fr/mesh/D008223",
"about": {
"@type": "MedicalCondition",
"name": "Lymphomes",
"code": {
"@type": "MedicalCode",
"code": "D008223",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.683.515.761"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphome intraoculaire",
"alternateName": "Intraocular Lymphoma",
"code": {
"@type": "MedicalCode",
"code": "D064090",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Gezhi Xu",
"url": "https://questionsmedicales.fr/author/Gezhi%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Satoru Kase",
"url": "https://questionsmedicales.fr/author/Satoru%20Kase",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Daiju Iwata",
"url": "https://questionsmedicales.fr/author/Daiju%20Iwata",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kayo Suzuki",
"url": "https://questionsmedicales.fr/author/Kayo%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
},
{
"@type": "Person",
"name": "Kenichi Namba",
"url": "https://questionsmedicales.fr/author/Kenichi%20Namba",
"affiliation": {
"@type": "Organization",
"name": "Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "ABO blood groups and nosocomial infection.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37009679",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0950268823000432"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of the frequency of ABO and Rh-Hr blood-group systems in different acquired cataracts type.",
"datePublished": "2023-09-30",
"url": "https://questionsmedicales.fr/article/37777774",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-023-06524-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "ABO blood groups and expression of blood group antigens of epithelial ovarian cancer in Chinese women.",
"datePublished": "2022-11-22",
"url": "https://questionsmedicales.fr/article/36415180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.5476"
}
},
{
"@type": "ScholarlyArticle",
"name": "ABO Blood Group and Bleeding and Survival in VA-ECMO Patients.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37291851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/08850666231178759"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of ABO and RhD blood groups with the risk of HIV infection.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37099490",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0284975"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndromes immunoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D007160"
},
{
"@type": "ListItem",
"position": 4,
"name": "Syndromes lymphoprolifératifs",
"item": "https://questionsmedicales.fr/mesh/D008232"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lymphomes",
"item": "https://questionsmedicales.fr/mesh/D008223"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphome intraoculaire",
"item": "https://questionsmedicales.fr/mesh/D064090"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphome intraoculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphome intraoculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphome intraoculaire",
"description": "Comment diagnostique-t-on un lymphome intraoculaire ?\nQuels tests sont utilisés pour confirmer le lymphome intraoculaire ?\nQuels signes cliniques indiquent un lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il être confondu avec d'autres maladies ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=ABO+Blood-Group+System#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphome intraoculaire",
"description": "Quels sont les symptômes courants du lymphome intraoculaire ?\nLe lymphome intraoculaire cause-t-il des changements de vision ?\nPeut-on avoir des symptômes sans douleur ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=ABO+Blood-Group+System#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphome intraoculaire",
"description": "Peut-on prévenir le lymphome intraoculaire ?\nQuels facteurs de risque sont associés au lymphome intraoculaire ?\nLes infections peuvent-elles être évitées pour réduire le risque ?\nLe dépistage précoce aide-t-il à la prévention ?\nY a-t-il des recommandations pour les personnes à risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=ABO+Blood-Group+System#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphome intraoculaire",
"description": "Quels traitements sont disponibles pour le lymphome intraoculaire ?\nLa chimiothérapie est-elle efficace pour ce type de lymphome ?\nLa radiothérapie est-elle utilisée dans le traitement ?\nQuand la chirurgie est-elle nécessaire ?\nY a-t-il des traitements expérimentaux disponibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=ABO+Blood-Group+System#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphome intraoculaire",
"description": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?\nLe lymphome intraoculaire peut-il entraîner des métastases ?\nComment le traitement peut-il causer des complications ?\nLe suivi régulier peut-il prévenir les complications ?\nQuelles sont les complications à long terme possibles ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=ABO+Blood-Group+System#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphome intraoculaire",
"description": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?\nLes antécédents familiaux augmentent-ils le risque ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nCertaines infections virales sont-elles des facteurs de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D064090?mesh_terms=ABO+Blood-Group+System#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un lymphome intraoculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par examen ophtalmologique, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le lymphome intraoculaire ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, l'IRM et l'analyse du liquide vitré."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un lymphome intraoculaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la vision floue, des douleurs oculaires et des lésions rétiniennes peuvent indiquer la maladie."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il être confondu avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec des infections ou d'autres tumeurs oculaires."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet d'analyser les cellules et de confirmer la présence de lymphome."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du lymphome intraoculaire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent vision floue, douleur, rougeur et décoloration de l'œil."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire cause-t-il des changements de vision ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut entraîner des changements de vision, y compris des taches ou des ombres."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans douleur ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent avoir des symptômes sans douleur oculaire significative."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'étendue et de la localisation du lymphome."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre et la perte de poids peuvent également survenir."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le lymphome intraoculaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés au lymphome intraoculaire ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, certaines infections virales et l'âge avancé."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être évitées pour réduire le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les infections virales comme le VIH peut réduire le risque de lymphome."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce aide-t-il à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce peut aider à identifier les problèmes oculaires avant qu'ils ne deviennent graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les personnes à risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes à risque devraient consulter régulièrement un ophtalmologiste pour un suivi."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le lymphome intraoculaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chimiothérapie, la radiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace pour ce type de lymphome ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie est souvent efficace, surtout pour les lymphomes non hodgkiniens."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée dans le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour cibler les cellules cancéreuses dans l'œil."
}
},
{
"@type": "Question",
"name": "Quand la chirurgie est-elle nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est envisagée si le lymphome provoque des complications ou ne répond pas aux autres traitements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements expérimentaux comme les thérapies ciblées sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le lymphome intraoculaire ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la perte de vision, le glaucome et des infections secondaires."
}
},
{
"@type": "Question",
"name": "Le lymphome intraoculaire peut-il entraîner des métastases ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut se propager à d'autres parties du corps, bien que ce soit rare."
}
},
{
"@type": "Question",
"name": "Comment le traitement peut-il causer des complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements comme la chimiothérapie peuvent affaiblir le système immunitaire, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Le suivi régulier peut-il prévenir les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier permet de détecter et de traiter rapidement les complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications à long terme possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications à long terme peuvent inclure des problèmes de vision persistants et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du lymphome intraoculaire ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, l'âge avancé et certaines infections."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux augmentent-ils le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de lymphome peuvent augmenter le risque de développer la maladie."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées, comme celles atteintes du VIH, ont un risque accru."
}
},
{
"@type": "Question",
"name": "Certaines infections virales sont-elles des facteurs de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections comme le virus Epstein-Barr sont associées à un risque accru de lymphome."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que l'exposition à des produits chimiques peut augmenter le risque de lymphome."
}
}
]
}
]
}
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Department of Ophthalmology, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Fudan University Eye and ENT Hospital, Fudan University, Shanghai, China; NHC Key Laboratory of Myopia (Fudan University); Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China. Electronic address: qngchang@aliyun.com.
Department of Ophthalmology and Visual Science, Catholic University Lymphoma Group, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
The timely identification of the high-risk groups for nosocomial infections (NIs) plays a vital role in its prevention and control. Therefore, it is crucial to investigate whether the ABO blood group ...
This study evaluated the relationship between acquired cataract's different types and the ABO and Rh blood classes....
Overall, 520 patients, by randomized sampling method, participated in this retrospective cross-sectional study. After reviewing the patient's medical records and laboratory results, the patient's demo...
A total of 520 patients were included in the research, with a mean age of 67.57 ± 11.85. Most of them were female (n = 286, 55%). Mix (n = 230, 44%) and nuclear sclerotic (NS) (n = 167, 32%) cataracts...
Although our findings showed that cataract types are independent of blood group types and Rh, they can be compared with future studies on the association of other Blood-Group Systems in developing acq...
ABO blood groups has been associated with risk of several cancers; however, the results for an association with ovarian cancer are inconsistent and little is known about the expression of histo-blood ...
To assess the impact of genotype-derived ABO blood types on the risk of EOC, we conducted a case-control study in 1,870 EOC and 4,829 controls. Expression of A and B antigen in 70 pairs of ovarian tum...
We identified that blood group A was associated with increased risk for EOC compared to blood group O (OR = 1.18, 95% CI = 1.03-1.36, p = 0.019). Increased frequency of aberrant expression of histo-bl...
We identified blood group A was associated with increased EOC risk in Chinese women and provided the clues of the possible molecular mechanisms of blood group A related to ovarian cancer risk....
ABO blood group has been shown to be a major determinant of plasma von Willebrand factor (vWF) levels. O blood group is associated with the lowest vWF levels and confers an increased risk of hemorrhag...
Naturally occurring antibodies against ABO antigens present in human sera have been shown to neutralize ABO-expressing HIV in vitro. We investigated associations between ABO and RhD blood groups and H...
Tn syndrome is an acquired form of polyagglutination arising from somatic mutations of hematopoietic stem cells. Tn red blood cells (RBCs) are agglutinable by naturally occurring anti-Tn antibodies in...
A 63-year-old man with myeloproliferative neoplasm, who historically typed as group O, demonstrated unexpected mixed field reactivity with anti-A reagent using a gel-based method. However, manual tube...
Lectin testing demonstrated reactivity with Salvia sclarea and Glycine soja, but not Arachis hypogea. The patient's RBCs produced positive crossmatches with healthy donor sera, but reactivity was elim...
This case of acquired Tn polyagglutination due to a novel mutation was first suspected from an ABO phenotyping discrepancy. It highlights the cross-reactivity of anti-A reagent with Tn antigen when te...
Blood transfusion, as well as organ transplantation, is only possible after prior blood group (BG) typing and crossmatching. The most important blood group system is that of Landsteiner's ABO classifi...
Evaluating the association of ABO blood group with different delayed hypersensitivity reactions, such as oral lichenoid reaction (OLR), can provide a new perspective for clinical practice. Therefore, ...
The ABO blood group (BG) system is of great importance for blood transfusion and organ transplantation. Since the same transcription factors (TFs) and microRNAs (miRNAs) govern the expression of ABO B...
Some studies show an increased risk of gestational diabetes mellitus for ABO blood groups. Others find a lower risk or do not identify any association. Inconsistencies may be due to the heterogeneity ...
This case-control study was conducted from February 2019 to December 2021 in Monterrey, Mexico, with 185 cases (women with gestational diabetes mellitus) and 530 controls. ABO blood groups and other v...
The ABO blood groups were O (69.4%), A (22.2%), B (6.7%), and AB (1.7%), with no differences between cases and controls (p = 0.884). No association was found between ABO blood groups and gestational d...
ABO blood groups were not associated with an increased risk of gestational diabetes mellitus in Mexican women, independent of gravidity and well-known risk factors....